Castle Biosciences (NASDAQ:CSTL – Get Rating) had its target price trimmed by Lake Street Capital from $41.00 to $32.00 in a research report released on Monday morning, The Fly reports. Other equities analysts have also recently issued research reports about the stock. Stephens reiterated an overweight rating and set a $41.00 price target on shares […]
Castle Biosciences (NASDAQ:CSTL – Get Rating) had its target price trimmed by Robert W. Baird from $35.00 to $25.00 in a research report report published on Monday morning, The Fly reports. Several other research analysts have also recently weighed in on CSTL. Lake Street Capital cut their price objective on Castle Biosciences from $63.00 to […]
Castle Biosciences (NASDAQ:CSTL – Get Rating) had its price target dropped by research analysts at Robert W. Baird from $35.00 to $25.00 in a report issued on Monday, The Fly reports. Robert W. Baird’s target price points to a potential upside of 69.84% from the stock’s previous close. Other equities research analysts also recently issued […]
Castle Biosciences (NASDAQ:CSTL – Get Rating) had its price objective decreased by equities research analysts at Scotiabank from $54.00 to $33.00 in a research note issued on Wednesday, The Fly reports. Scotiabank’s price target suggests a potential upside of 124.34% from the company’s current price. A number of other equities analysts also recently weighed in […]
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Rating) insider Derek J. Maetzold sold 1,538 shares of the firm’s stock in a transaction that occurred on Monday, May 15th. The shares were sold at an average price of $23.45, for a total value of $36,066.10. Following the completion of the sale, the insider now directly owns 150,443 […]